ArticleBMC medical imaging2024

A noninvasive method for predicting clinically significant prostate cancer using magnetic resonance imaging combined with PRKY promoter methylation level: a machine learning study.

Yufei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.